ACP and OpenEvidence Partner to Advance Clinical AI
Miami, Florida, and Philadelphia, Pennsylvania, United States, November 9, 2026 The American College of Physicians (ACP) and OpenEvidence have...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
Miami, Florida, and Philadelphia, Pennsylvania, United States, November 9, 2026 The American College of Physicians (ACP) and OpenEvidence have...
Thousand Oaks, California, United States, November 9, 2026 Amgen has announced new clinical and health economic findings at the...
Foster City, California, United States, November 9, 2026 OrthoTrophix, Inc. has announced new clinical research findings from two scientific...
Valencia, California, United States, November 9, 2026 SetPoint Medical has announced encouraging 24-month clinical data demonstrating sustained treatment benefits...
Suzhou, China, and Mölndal, Sweden, November 9, 2026 Suzhou Ribo Life Science Co., Ltd. and its subsidiary Ribocure Pharmaceuticals...
New Taipei City, Taiwan, November 9, 2026 GlycoNex, Inc., a clinical-stage biotechnology company focused on antibody-drug conjugates (ADCs) and...
Beijing, China, November 8, 2026 InnoCare Pharma has announced that the first patient has been dosed in its registrational...
Tarrytown, New York, United States, November 8, 2026 Regeneron Pharmaceuticals, Inc. has announced encouraging first-in-human clinical findings for its...
San Francisco, California, United States, November 9, 2026 Vir Biotechnology, Inc. has announced positive topline results from its pivotal...
Princeton, New Jersey, United States, November 6, 2026 Bristol Myers Squibb (BMS) has presented positive 56-week findings from its...
